Kewen Hu
- Molecular Biology
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine top 10%
- Biomedical Engineering
- Oncology
- Co-authors
- Xiufeng PangMingyao LiuWenhao JiangQiang ZhangZhengjie ZhouYiyun ChengKun LiJieqiong Wang
- Topics
- Nanoplatforms for cancer theranostics (3 papers)Extracellular vesicles in disease (2 papers)Protein Tyrosine Phosphatases (2 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Kewen Hu
12 papers receiving 908 citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Molecular Biology 609
- Cancer Research 241
- Pulmonary and Respiratory Medicine 223
- Biomedical Engineering 211
- Oncology 176
Countries citing papers authored by Kewen Hu
This map shows the geographic impact of Kewen Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kewen Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kewen Hu more than expected).
Fields of papers citing papers by Kewen Hu
This network shows the impact of papers produced by Kewen Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kewen Hu. The network helps show where Kewen Hu may publish in the future.
Co-authorship network of co-authors of Kewen Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Kewen Hu. A scholar is included among the top collaborators of Kewen Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kewen Hu. Kewen Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 50 | |
| 2 | 23 | |
| 3 | 24 | |
| 4 | 18 | |
| 5 | 22 | |
| 6 | Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinomabreakdown → | 287 |
| 7 | 167 | |
| 8 | 131 | |
| 9 | 80 | |
| 10 | 2 | |
| 11 | 45 | |
| 12 | 64 |
About Kewen Hu
Kewen Hu is a scholar working on Oncology, Molecular Biology and Biochemistry, having authored 12 papers that have together received 913 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (3 papers), Extracellular vesicles in disease (2 papers) and Protein Tyrosine Phosphatases (2 papers). The work is most often cited by research in Cancer Research (241 citations), Business and International Management (25 citations) and Molecular Biology (609 citations). Kewen Hu has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Xiufeng Pang, Mingyao Liu, Wenhao Jiang, Qiang Zhang, Zhengjie Zhou, Yiyun Cheng, Kun Li, Jieqiong Wang, Feixiong Cheng and Jing Lv. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.